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S U M M A R Y
The N-ja-phenyl-(5-substituted-2-hydroxy- 
benzylidene)J -amino acids react smoothly with amino 
acyl polymers in the presence of N,N'-dicyclohexylcarbo 
diimide (DCC) to afford the ketimine peptide resin 
esters in quantitative yield. Several N-protected 
dipeptide resin esters were synthesized and 
characterized as their methyl ester derivatives.
The ketimine protecting group was found to be 
remarkably stable to hydrolysis when incorporated 
into a Merrifield resin, in fact no suitable method 
for its removal from peptide resins could be 
developed. This unusual stability of the 
diarylmethylene protecting group when incorporated 
into a Merrifield type styrene divinylbenzene 
polymer support suggested its suitability for the 
side chain protection of ornithine and lysine in . 
solid phase peptide synthesis.
The Na-t-butyloxycarbonyl-Ne-Ja-phenyl- 
(5-substituted-2-hydroxybenzylidene)]-L-lysine and 
ornithine have been synthesized and coupled with 
valine or alanine resins to form N-protected 
peptide resin esters. The ketimine protecting 
group was stable under anhydrous acidic conditions 
and the urethane blocking group could be removed
s - 2 -
preferentially from the ot-amino function. Several 
lysine and ornithine containing tetrapeptides 
have been synthesized by the solid phase technique.
' I N T R O D U C T I O N
3
A. GENERAL INTRODUCTION
The synthesis of peptides is important 
for an understanding of protein function and where 
the biological activity of peptides resides. The 
first successful synthesis of a dipeptide was due 
to Fischer1, who introduced a method of simultaneous 
carboxyl activation and amino protection. He 
synthesized 2,5-diketopiperazine (1) which could 
be hydrolyzed to yield the free dipeptide. This 
route is only applicable for the preparation of 
dipeptides. Immediately following Fischer!s 
publications, Curtius2, developed a general 
synthetic route for the preparation of peptides.
In this procedure, acyl amino acid esters were 
converted to the corresponding hydrazides, which 
on treatment with nitrous acid gave the reactive 
azides. The synthetic route is shown in Fig (2).
The azides are good acylating agents and they react 
with the free amino group of a second amino acid 
to yield the acyl dipeptides. The azide method 
can be extended for the preparation of longer 
chain peptides. In recent years, the synthesis of 
physiologically active peptides has become a reality
3and recently the first partially active enzyme has 
been synthesized.
H
HR -Ô ------ C 30
/  \H-N N-H
A
(1)
XN H -CH R -CO O R 1 + H2N-NH2 ---------» XNH-CHR-CONHNH2
XNH-CHR-CONHNH + HONO --------- > X N H -CH R -CO N ,
x n h - c h r - c o n 3 + H2N -C H R ’ '-C O O Y
XN H -CH R-CON H-CH R' '-C O O Y
(2)
5
The synthesis of a peptide requires the 
formation of an amide bond through acylation of 
the amino group of one amino acid (1) by a second 
amino acid (11). Fig (3).
h 2n -c h r -c o o h +
(I)
H2N-CHR-CONH-CHR -COOH
(3)
Since each amino acid contains at least one amino 
and one carboxyl group, they both can act as 
acylating agents or as the amino acids to be 
acylated. Therefore, such a reaction can lead to 
at least three different dipeptides. Since only 
one peptide product is desired, it is necessary to 
protect the amino group of (I) and the carboxyl 
group of (II). Similarly, all other functional 
group of any polyfunctional amino acid, such as 
glutamic acid and lysine, which are to be 
incorporated into the peptide chain must be 
protected.
6
In the synthesis of a polypeptide, two
broad types of protecting groups are required, one 
which intermittently protects amino and carboxyl 
groups and liberates them selectively and a 
second type which permanently blocks other reactive 
functional groups. All of these protecting groups 
must finally be capable of removal under conditions 
which do not damage the sensitive peptide product. 
Since most peptides are stable under mild, acidic 
conditions, it is most convenient to choose 
combinations of protecting groups which can be 
selectively removed under acidic conditions.
groups in peptide synthesis are those based on 
benzyl and t-butyl residues. For amino protection 
these residues are used in the form of the
benzyloxycarbonyl (Z) (Ha) and the t-butyloxycarbonyl
5 5 6
(Boc) (Hb) groups. Their counterparts for
carboxyl group protection are the benzyl (Bzl) (He)
The most extensively used protecting
7
(Ha) (Hb)
7
Uc) (4d)
The benzyloxycarbonyl (Z), which was
k
first introduced in 1932 by Bergmann and Zervas , 
is extremely useful for the protection of amino 
groups. The Z-derivatives,of amino acids are 
readily prepared, are stable, and the protecting 
group can be easily removed without hydrolysis 
of the peptide bond. The N-protected amino acid 
derivatives can be easily prepared by reaction 
of the amino acid with carbobenzoxy chloride in 
slightly alkaline conditions. The Z-protecting 
group can be removed by a variety of methods, 
such as, hydrogenolysis, reduction with sodium 
in liquid ammonia or with hydrogen bromide in 
acetic acid.
The t-butyloxycarbonyl (Boc) group, 
which was introduced simultaneously by Me Kay 8
5 6
Albertson and Anderson 8 Me Gregor in 1957, has
8
proved to be an even more useful protecting group.
The Boc-amino acid derivatives can be prepared by
9the Schnabel method , which involves a reaction of
the amino acid with Boc-azide at pH 9.8. Alternatively,
it can also be prepared by the procedure known as
1 othe Schwyzer method , which involves a reaction 
of the amino acid, Boc-azide in the presence of
omagnesium oxide at H0-50 C for 20 hours. The 
cleavage of the Boc group can be carried out with 
50% trifluoroacetic acid in dichloromethane at 
room temperature. Within a short time, complete 
removal of the Boc group can be achieved. The 
Boc—amino acid derivatives are now commercially 
available and are the most popular starting materials 
for peptide synthesis.
Since the benzyl and t-butyl residues 
are each selectively removable in the presence of 
the other, it is possible to use one type of residue 
as a means of intermittent protection while the 
other type is used to mask side chain functions 
throughout the synthesis. The presence of 
polyfunctional amino acids such as lysine and 
glutamic acid introduces a number of restrictions 
in the selection of the remaining protecting groups 
and their subsequent removal. With diamino- 
monocarboxylic.acids such as lysine and ornithine,
the protecting group used for the side chain amino
function must remain attached during the condensation
and deblocking processes. It is therefore necessary
to introduce another type of a- amino protecting
group which can be selectively removed in the
presence of other side chain blocking group. The
11o-nitrophenylsulphenyl (Nps) and 2-(p-biphenyl)-
12isopropyloxycarbonyl (Bpoc) are most suitable for 
this purpose. Since the Nps group is extremely 
sensitive to acids and can be cleaved selectively 
in the presence of a carbobenzoxy group, it has 
been used for a-amino protection of lysine and 
ornithine.
- 9 -
Another acid labile blocking group worthy
1 3of mention is the triphenylmethyl (trityl) residue , 
which can be cleaved without the removal of the Boc 
group. Dilute acetic acid at room temperature will 
remove the trityl group completely. The use of 
an acid labile protecting group is advantageous for 
a lengthening of a peptide chain which includes 
amino acids bearing functional group in their side 
chain.
The use of Schiff base derivatives of 
amino acids as a means of acid labile a-amino group 
protection for the synthesis of peptides has
10
also been reported. There are a number of- methods
used for the preparation of Schiff base derivatives
of amino acids. Mclntire investigated the reaction
of a number of aromatic aldehydes with free amino
acids. Of the several different aromatic aldehydes
examined for Schiff base formation, only the
o-hydroxyaldehyde yielded Schiff bases which could 
1 ̂
be isolated . Crystalline amino acid derivatives 
of 5-chlorosalicylaldehyde (5a) and 2-hydroxy-l- 
napthalaldehyde (5b) have been prepared.
The increased stability of these o-phenolic aldehyde 
derivatives was attributed to the formation of 
strong intramolecular hydrogen bond between the
1 5
phenolic proton and the imine nitrogen atom .
The compounds were later used by Sheehan 
1 6
and Grenda in peptide synthesis but only some 
N-terminal valine dipeptide esters were prepared.
11
1 7
. Hope and Halpern reported a new method 
for preparation of sterically pure crystalline 
derivatives of o-hydroxy substituted aromatic ketones 
with free amino acids. In this method, amino acids 
were first converted to their tétraméthylammonium 
salts which are condensed with o-hydroxy aromatic 
ketones in anhydrous medium in the presence of 
molecular sieve. The new approach is superior 
to Me.IntireTs method as the tétraméthylammonium 
salts of amino acid are more soluble in alcoholic 
solvents than the respective sodium and potassium 
salts and thus the condensation reaction is faster 
and proceeds to completion at room temperature.
The ketimine derivatives can usually be isolated as 
the free acids by careful acidification of the 
tétraméthylammonium salts. The new synthetic route 
is outlined schematically in fig (6)
The o-hydroxy aromatic ketones could be
condensed with all the protein amino acids, except
proline, to yield yellow crystalline optically
1 8pure ketimine derivatives . The two most useful 
o-hydroxy aromatic ketones for this reaction are 
5-chloro-2-hydroxybenzophenone (7) and 2-hydroxy- 
5-methylbenzophenone (8)
All these ketimine derivatives are shown
12
+ ! - - +H 3N-CHR-C00 + (CH3)4N j OH----» H2N-CHR-COO N(CH3)l+
+ H20
(I)
(I)
R'\
+ .c=o
R\ - t» C = N-CHR-COO N (CH0)„
\
R
C=N-CHR-COOH
OH
(6)
13
to have an ultraviolet absorption near 220 nm 
(log e about 4) which is indicative of an
1 9
azomethine bond * and they showed bands in the 
infrared near 1715 and 1610 cm“1 which can be 
assigned to the imine function ^C=N. The proton 
magnetic resonance (p.m.r) spectrum of glycine 
and alanine derivatives confirmed the Schiff base 
formulât ion (9)
Ph
\c=o R = CgHj- , R' = Cl (7)
R = CgH&, R'  = CH,  (8)
Ph
\C=N-CHR-C00H
R = CcHc b d
R ’ 1 = Cl or CH3
(9)
The postulated structure of (9) was also confirmed 
by Electron Impact Hass Spectrometry as (9) gave 
rise to a characteristic ion (10) which is formed 
by the loss of 44 mass unit (CC^) from the molecular 
ion. This ion (10) can be conveniently used to
14
identify the particular amino acid.
\
OH
C=N-CH„R (10)
The N-(2-hydroxyarylmethylene) amino
acids are soluble in most organic solvents and are 
stable under the condition commonly used in peptide 
synthesis. The increased stability of these 
derivatives may be due to the presence of the 
o-hydroxy group in the aromatic ketones and the 
resulting hydrogen bonding prevents the cleavage of 
the imine bond during the peptide bond formation.
Racemization of optically active amino
acids protected by the diarylmethylene system is
not possible through the classical azlactonization 
2 0 ) 2 1
mechanism generally proposed for N-acylated
amino acids, although other base catalysed
mechanisms for racemizatioh can be postulated.
The steric purity of these derivatives has been
confirmed by gas liquid chromatographic (g.l.c)
analysis of diastereoisomeric amino acid 
2 2
derivatives . .
15
The main advantages associated with the use of 
ketimine derivatives are, firstly, their convenient 
solubility in many organic solvents commonly used 
for the peptide coupling reaction. Secondly, the 
ketimine derivatives can be readily condensed by 
the use of coupling reagent such as N,N'-dicyclohexyl-
2 3
carbodiimide (DCC) without the danger of 
racemization. Thirdly, the ketimine derivatives 
of amino acids and peptides are coloured and thus 
are readily detected in most chromatographic 
purification procedures.
16
B. INTRODUCTION TO SOLID PHASE PEPTIDE SYNTHESIS.
2 % 5 2 5In 1962, Merrifield developed a new
approach to the chemical synthesis of polypeptides.
In this method, the carboxyl terminal amino acid of the 
peptide to be~ synthesized, is covalently linked to 
an insoluble solid support, and the peptide is built 
up by stepwise addition of amino acids from the 
carboxyl end according to the scheme in (11)
The solid support is a chloromethylated 
polystyrene-divinylbenzene resin (1). The 
chloromethyl groups of the resin can be reacted with 
the carboxyl group of the N-protected amino acid 
to form an amino acyl resin (2). The protecting 
group, Y, must be sufficiently labile so that it 
can be selectively removed without damage to the 
ester bond linking the amino acid to the polymer.
After removal of the protecting group, a second 
N-protected amino acid (3) may be coupled to the 
^mino acid resin to form the N-protected dipeptide 
resin (H). The deprotection and coupling steps 
may be repeated using the next N-protected amino 
acid until the desired sequence assembled to the 
polymer support. At the end of the synthesis, the 
finished peptide is cleaved from the resin using
2 6an appropriate reagent such as hydrogen fluoride .
17
XNH-CHR ' -COOH + Y-jPolymep) Q )
1
XNH-CHR1 -COO-|PÔÎÿmëri (2)
deprotect
*
XNH-CHR"-CO OH + H^N-CHR ' -COO-lPolvm'ërl (3)
couple
XNH-CHR"-CONH-CHR'-COO-|PÔlvmer| (n)
cleave
H 2N-CHR"-CONH-CHR'-COOH + IPolymer
(11)
18
Since the peptide product is always insoluble 
in the solvents used for the synthesis, the 
intermediate and final products can be readily 
recovered by a simple filtration. Since the whole 
synthesis can be carried out in a single reaction 
vessel, losses due to repeated transfer of material 
are avoided. The reaction must be forced to completion 
at each step in order to obtain a homogeneous 
product, and this is usually done by the use of excess 
reactants and long reaction times. Peptide synthesis 
by the Merrifield procedure are considerably faster 
than the classical route and better yields are 
generally obtained. The Merrifield technique has 
been used to synthesize a wide range of peptides 
containing all the protein amino acids. The largest 
peptides synthesized by this method so far are
2 7 2 0insulin and ferredoxin .
An automated solid phase synthesizer 
which can attach up to six amino acid residues to
2 9)30the resin per day has been developed .
The Boc-amino acids are the most 
preferred amino acid derivatives for solid phase 
synthesis and they can be satisfactorily attached 
to the chloromethylated resin. The coupling reagents 
most commonly employed in solid phase synthesis are
31 32)33the oarbodiimides and the active esters .
19
The N,N*-dicyclohexylcarbodiimide is commercially 
availablej inexpensive, and convenient to use.
Active esters, such as p-nitrophenyl esters have also 
been used for the synthesis of several large peptides,
3 ksuch as insulin .
The ease of removal of the diarylmethylene 
protecting group by dilute acid suggested its use 
for the a-amino protection in solid phase peptide , 
synthesis and this is the subject of this work.
D I S C U S S I O N
20
Application of ketimine derivatives of Amino Acids 
in Solid Phase Peptide Synthesis,
The N- j*a-phenyl-( 5-chloro-2-^hydroxy- 
benzylidene)] (Abbr. 5-C1B) and N-[a-phenyl-(2- 
hydroxy-5-methylbenzylidene)] (Abbr. 5-MeB) amino 
acid derivatives have been reacted with a Merrifield 
type styrene divinylbenzene support yielding the 
corresponding N-protected amino acyl resins.
Several of these ketimine amino acyl resins were 
prepared using the standard esterification
3 5)36procedures , in which the N-ketimine amino acid
derivatives and the resin were refluxed with stirring in 
absolute ethanol in the presence of triethylamine
for forty eight hours. The amino acid content of. 3 7the resin was determined, by direct mass spectroscopy .
In this method, the ketimine amino acid resin was 
hydrolyzed with 6 N HC1 and transferred to a 
micro reaction vial with a known amount of stable 
isotopically labelled amino acid internal standard.
The free amino acids were then converted to N-acetyl 
amino acid methyl ester derivatives for mass 
spectrometric/analysis. The amino acid content of 
the resins were comparable with those obtainable 
with Boc-amino acids using the same published 
conditions. See table (12)
21
Amino Acid content of chloromethyl resin using Boc - 
amino acid and ketimine amino acid derivatives.
Table (12)
Amino Acid content in 1 gram of Resin of 
Boc-A.A-Resin Esters Ketimine-A.A-Resin Esters
Glycine SÌ-CO•o mmole 0.30 mmole
Alanine 0.2H 5 5 0.27 5 5
Valine 0.32 >  5 0.32 5 5
Leucine 0.36 5 » 0.29 5 >
Although the diarymethylene protecting 
group is removed with relative ease from N-protected
1 7peptide methyl ester with dilute acid , it is 
remarkably stabilized when incorporated into the 
Merrifield type resin support. This was shown by
f
taking a portion of 5-ClB-L-alanyl-resin ester (0.5 g) 
and treating it with 80% acetic acid at room 
temperature for six hours, the resin still retained 
the yellow colour and only a trace of ketone was 
detectable in the mother liquor. A further portion 
was treated with trifluoroacetic acid in dichloro- 
methane for 30 minutes and the colour of the resin 
was still bright yellow which indicated that the 
ketimine amino acid was still attached to the resin. 
The thin layer chromatogram of the extract showed 
no evidence of cleavage of the diarylmethylene group.
22
A satisfactory method for removal of the 
diarylmethylene group from amino acyl resins 
without hydrolysis of the amino acid-resin bond 
has not been found. To demonstrate further the 
stability of the diarylmethylene group when 
attached to an amino acid resin we prepared 5-C1B- 
glycyl-L-phenylalanyl-resin ester using N,N'-dicyclo­
hexyl car bod iimide' (DCC) as the coupling agent.
Treatment of the resulting ketimine peptide 
resin with aqueous acetic acid or aqueous hydrogen 
chloride (4N) did not remove the yellow colour.
T.l.c of the extract showed no evidence of 
cleavage of the diarylmethylene group. The 
presence of 5-ClB-glycyl-L-phenylalanine methyl 
ester on the resin was confirmed by transesterification 
with methanol in the presence of triethylamine 
followed by C.I mass spectrometry of the product.
This showed a molecular ion m/e 451 (MH+). The 
recovered material was shown to be identical by 
t.l.c and mixed melting point with authentic 
5-ClB-glycyl-L-phenylalanine methyl ester prepared 
by condensation of 5-ClB-glycine with L-phenylalanine 
methyl ester in solution. This surprising stability 
of the ketimine function was confirmed with a 
number of other ketimine peptide resins and in all 
cases the ketimine peptide methyl ester could be 
recovered unchanged by transesterification.
23
This increased stability of the ketimine 
amino ac'id resin esters may be due to an inability 
of the water needed for the hydrolysis to 
penetrate the resin beads. Also, it has been 
shown that the peptide chain are contained within 
the pores of the beads (13). This suggested 
that ketimine dipeptide acyl resin should be stable 
under anhydrous acid conditions such as treatment 
with trifluoroacetic acid:dichloromethane (1:1).
This was shown to be so and no evidence of
hydrolysis of the diarylmethylene function was
detected by t.l.c. A satisfactory method for
the removal of the diarylmethylene protecting
group from the amino or peptide acyl resin
without hydrolysis of the amino acid-resin bond
has not been found to date. Thus, the approach
of using this group for a-amino protection in
solid phase synthesis was obviously not feasible.
However, the remarkable stability of the diarylmethylene
group when incorporated into a Merrifield type
resin suggested that the protecting group might
be suitable for side chain protection of amino
functions in solid phase peptide synthesis.
In the synthesis of peptides containing lysine 
or ornithine residues, it is necessary to 
protect the e-amino group permanently during
(13)
the synthesis. When the t-butyloxycarbonyl (Boc) 
is used for the protection of the a-amino . 
function, the side chain protecting group must 
remain intact during acidolysis of the Boc- 
groups. Up to now the carbobenzoxy (Z) group 
has been used for this purpose, but it has been 
shown recently this causes difficulties, because 
acidolytic deprotection of the Na-Boc group 
brings about some cleavage of the Z-protecting
3 8 , 3 9group . The loss of some of the N -
protecting group from a lysine residue during the 
deprotection of the Na-Boc group will generate 
a free e-amino group which can couple with an 
activated amino acid to form a branched peptide 
chain. This can be a serious problem; for 
example in a recent synthesis of a deca-lysyl- 
valine peptide, the product was shown to contain 
some 30% of unwanted branched chain peptides .
We have now investigated the application 
of the diarymethylene group for side chain 
protection of ornithine and lysine in solid 
phase synthesis. To test this approach it was 
necessary to synthesize the N -Boc-N -5MeB~L- 
lysine (14) and Na-Boc-N^-5ClB-L-ornithine (15) 
derivatives for use in solid phase peptide 
synthesis. These derivatives could be prepared by
25
a condensation reaction of 2-hydroxy-5-methyl-
benzophenone and 5-chloro-2-hydroxybenzophenone
with the tetramethylammonium salts of N tt-Boc-L- 
. cxlysine and N -Boc-L-ornithine. .
Ph\C=N-(CH2)1+-CH(NHCOOC(CH3)3COOH 
OH
(14)
Ph\C=N-(CH2)3-CH(NHCOOC(CH3)3COOH
.OH
C l ^ ^
(15)
The resulting ketimine dérivatives could be isolated 
as the free acids by a careful acidification of 
the tetramethylammonium salts to a pH between 5-6, 
Both ketimine derivatives showed bands in the
-26 -
infrared region near 1715 cm~^ and 1610 cm~^.
Their structure was confirmed by C.I mass
spectrometry of the products which yielded molecular
ion at m/e 396 (MH+-C00H) for Na-Boc-Ne-5MeB-L-
lysine (14) and m/e 402 (MH+-C00H) for I^-Boc-N6-
5ClB-L-ornithine (15). The compound (14) and (15)
could be coupled with valine and alanine resins
respectively to yield the Na-Boc-Ne-5MeB-L-lysyl-
L-valine resin ester (16) and the I^-Boc-N^-SCIB-
L-ornithyl-L-alanine resin ester (18). The
presence.of these peptides on the resins could
be confirmed by a treatment with triethylamine- 
*♦ 2
methanol which yielded the corresponding methyl 
esters. The C.I mass spectrometry of these 
derivatives gave molecular ion at m/e 554 (MH+) 
for Na-Boc-Ne-5MeB-L-lysyl-L-valine methyl ester 
(17) and m/e 532 (MH+) for Na-Boc-N6-5ClB-L- 
ornithyl-L-alanine methyl ester (19). The Boc- 
group of the respective resin esters (16,18) 
could be removed by 30 minutes treatment with 
trifluoroacetic acid-dichloromethane (1:1). The 
diarylmethylene group remained intact under these 
conditions as the resins retained their bright 
yellow colour during the Boc deprotection step.
The free dipeptide resin esters were then treated 
with an excess of Boc-glycine in dichloromethane 
and the N,N'-dicyclohexylcarbodiimide coupling 
reagent.
27
Ph
\ C = N ( CH2 ) ^CH (NHCOOC ( CH3 ) 3 ) CONHCHR]LCOY
OH
(16)
Triethylamine/MeOH
Ph \ C=N(CH2 ) 1+CH(NHCOOC(CH3 ) 3 )CONHCHR1COOCH3
OH
(17) R ± = CH-(CH3)2 
Y = O-Polymer
PhV-
Cl
C=N(CH„),CH(NHCOOC(CH,).)CONHCHR„COY ‘ 2 3 3 3 2
OH
(18)
Triethylamine/MeOH
Ph
\
Cl
.C=N(CH2 ) 3CH(NHCOOC (CH3 ) )CONHCHR2COOCH3 
OH
(19) R2 = CH3
Y - O-Polymer
28
After 2^ hours at room temperature, the excess reagent
was removed by washing the resin with a suitable
solvent. The presence of tripeptides on the resins
were confirmed by a transesterification with
triethylamine-methanol. In both cases, Boc-glycyl- 
£N -5MeB-L-lysyl-L-valine methyl ester (20) and Boc- 
glycyl-N -5ClB-L,-ornithyl-L-alanine-methyl ester (21) 
were obtained in good yield. The identities of 
these compounds were established by t.l.c; amino 
acid analysis; and C.I mass spectrometry, m/e 611 
(MH ) and.m/e 589 (MH+) respectively. A flow 
chart of• these syntheses is shown in fig (22)
(c h 3)3c o c o n h c h 2c o n h c h c o n h c h r’coy
R ’ = CH(CH3)2
Y - 0-Polymer
(CH0)oC0C0NHCHoC0NHCHC0NHCHR”C0Y 3 3 2
w 3 RM CH
N OH
Cl
(21)
Y = 0-Polymer
29
Gly Lys Val
Boc
Boc
Boc
N-5MeB
Boc £N-5MeB
Boc
N-5MeB
OH NH2 ̂
DCC
N -5M eB ^
£N-5MeB
Boc
H
OH NH, 
DCC
H
Et3N/MeOH
Resin
Resin
Resin
Resin
Resin
OCH.
£
, (22)
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In order to test the suitability of the 
diarylmethylene protecting group for e-amino group 
protection, we also synthesized tetrapeptides 
containing lysine and ornithine using the scheme 
outlined in fig (23) . In all these syntheses, the 
t-butyloxycarbonyl (Boc) function was used for 
a-amino group protection and in all cases the 
coupling reaction was carried out with N,N’ - dicyclo- 
hexylcarbodiimide (DCC) in dichloromethane.
After peptide condensation the byproduct of the 
reaction U,N1-dicyclohexylurea was removed by 
washing the resin esters with methanol and ethanol.
In this synthesis, the Boc-L-valine resin ester 
and Boc-L-alanine resin ester starting materials 
were deprotected with trifluoroacetic acid: 
dichloromethane (1:1). After each deprotection 
step, the resin effluent was checked for any 
evidence of ketone in the washings by concentrating 
the solution and running the residue on t.l.c 
(benzene). In all cases, no indication of any 
ketone could be found. The resulting tetrapeptide 
resin esters were shown to homogeneous by
conversion to their methyl ester derivatives
\(triethylamine-methanol) followed by t.l.c.
These compounds were readily detected on the 
chromatogram due to their yellow colour. To 
establish the presence of peptides and amino acid
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derivatives without the side ketimine group in the 
transesterification products, the chromatogram were«♦ 3also sprayed with a hypochlorite- o-tolidine spray . 
This is used for visualizing peptide bond compounds. 
Again no unprotected peptide products could be 
detected. The amino acid contentof the tetrapeptides 
was confirmed by acid hydrolysis followed by
3 7direct C.I mass spectrometry . In this method, the 
amino acid mixtures obtained from the hydrolysis of 
the peptide were transferred to a micro reaction 
vial and a known amount of deuterium or N labelled 
amino acid internal standard was added. The 
solutions were then evaporated to dryness under a 
^stream of nitrogen and treated with acetic anhydride­
methanol which converts the amino acids to their 
N-acetyl amino acid methyl ester derivatives. The 
solutions were then transferred into capillary 
tubes, evaporated to dryness, and admitted through the 
insertion probe for direct spectrometric analysis.
The amino acid analysis of the product glycylglycyl- 
lysylvaline were found to be gly 2.08, lys 0.96, and 
val 1.00 and for glycylglycylornithylalanine were 
shown to be gly 1.96, and ala 1.00. Ornithine 
was not determined because no isotopically labelled 
standard was available.
. Our results suggest that the 
diarylmethylene protecting groups are suitable for
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side chain protection of lysine and ornithine in 
solid phase synthesis and that the method has 
distinct advantages over the conventional^carbobenzoxy 
derivatives of lysine and ornithine.
E X P E R I M E N T A L
• 35
GENERAL
Melting points were determined using a 
Reichert hot-stage microscope and are uncorrected. 
All the temperatures are expressed in degrees 
Celcius.
Optical rotations were measured on a 
Carl Zeiss circle .01 manual polarimeter using a 
0.5 dm tube.
Infrared spectra were recorded on a 
Perkin Elmer 357 grating spectrophotometer. P.m.r 
spectra were determined using a Jeolco JNM-4H-100 
machine with tetramethylsilane as internal 
reference.
Mass spectra were obtained from a Du Pont 
21-491B instrument.
Microanalysis were performed by Dr. E. 
Challen of the University of New South Wales and 
by the Australian Microanalytical Service, CSIRO, 
Melbourne.
Column chromatography of peptide 
derivatives was carried using Merck silica gel.
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Thin layer charomatography (t-.l.c) was performed 
with Merck silica gel G (0.025** layers). Rf 
values should be taken as a guide only. Schiff base 
derivatives could be visualized directly or by 
exposure to iodine vapour. Peptide bonds were 
detected by the hypochlorite-o-tolidine method 
and the free amino groups were detected with 
ninhydrin.
Light petroleum refers to the fraction 
b.p. 60-80 C.
Combined organic phases from extracts 
were dried with anhydrous magnesium sulphate.
Anhydrous solvents were employed in 
condensation, coupling and recrystallization steps 
involving the Schiff bases.
Molecular sieve type 3A (1/16** pellets) 
was manufactured by the Linde Air Products Co. 
and distributed by BDH Chemicals (Poole, England)
Amino acids and amino acid derivatives 
used in the condensation were supplied by Fluka 
(Buchs, Switzerland), Bachem Inc. (Marina Del Rey, 
California), Sigma Chemical Co. (St Louis,
Missouri and BDH Chemicals (Poole, England).
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The ketones were obtained from Pfaltz 
and Bauer (Flushing, New York).
The Boc amino acyl resins used for 
Solid phase synthesis were purchased from Schwarz­
Mann (Orangeburg, New York). Merrifield resin was 
supplied by the Pierce Chemical Co. (Rockford, 
Illinois).
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Preparation of Amino Acid Methyl Ester Hydrochlorides.
Methyl esters of glycine and phenyl­
alanine were prepared by the method of Brenner and 
Huber
H 5To dried methanol cooled in dry 
ice-acetone was added freshly distilled thionyl 
chloride (0.7 ml). The amino acid (1 g) was then 
refluxed for H5 minutes with the methylsulphonyl 
chloride reagent. After evaporation of the 
solvent, the crystalline residue was twice 
redissolved in alcohol and again evaporated and 
the ester hydrochloride was finally recrystallized 
from methanol-ether mixture.
Preparation of Tétraméthylammonium Hydroxide 
Solution.
A mixture of tétraméthylammonium 
bromide (6.16 g, 40 mmole) and silver oxide 
(7.0 g, 30 mmole) was stirred for 1 hour in methanol 
(70 ml), then filtered. The filtrate was diluted 
to 100 ml with methanol and the correct strength 
of the base (approximately 0.4 mmole/ml) was then 
determined by titration of an aliquot with standard 
sulphuric acid solution using phenolphthalein as
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an indicator. The solution can be kept
. osatisfactorily when stored at 0 C over molecular
sieves (3A).
Preparation of Dicyclohexylamine Solution.
Freshly distilled dicyclohexylamine
(7.96 ml, 40 mmole) was diluted to 100 ml with
methanol and stored over 3A molecular sieves 
o .at 0 C. The strength of the solution (approximately 
0.4 mmole/ml) was determined by titration of an 
aliquot with standard hydrochloric acid using 
bromocresol green-methyl orange (5:1) mixed 
indicator .
A . General Procedure for the preparation of 
N- [a-phenyl-(5-substituted-2-hydroxybenzylidene)] 
Amino Acids.
A mixture of the amino acid ( 3 mmole), 
tétraméthylammonium hydroxide solution ( 3 mmole) 
and the appropriate ketone ( 3 mmole) was diluted 
with methanol ( 20 ml) and the mixture was kept 
over molecular sieves (3A) until a homogeneous 
solution resulted ( from 1 to 10 days). After 
removal of the solvent on a rotary evaporator, 
water (40 ml) was added and the unreacted ketone
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starting material was filtered off. The pH of the 
filtrate was then adjusted to between 5-6 by 
careful addition of 20% citric acid solution and 
the Schiff base was extracted into ethyl acetate­
ether (9:1) solution. The dried residue was 
recrystallized using ethyl acetate and light 
petroleum ether.
Preparation of N- [a-phenyl-(5-chloro-2-hydroxy-
benzylidene) -glycine (I)
Glycine (225 mg, 3 mmole), tétraméthyl­
ammonium hydroxide (2.46 ml/mmole, 3mmole) and 
5-chloro-2-hydroxybenzophenone (698 mg, 3 mmole) 
were diluted with methanol ( 20 ml) and the 
reaction mixture was kept over a few sticks of 
molecular sieves (3A) for several days until a 
homogeneous solution resulted. The mixture was
worked up as described in A. Yield 564 mg (65%);
° +m.p 158-160 C; mass spectrum m/e 245 (MH -C00H);
Found C, 61.8; H, 4.4; N, 4.8. Ci5H12C1N03
requires C, 62.2; H,4.1; N, 4.8 %.
Preparation of N- [ot-phenyl-(5-chloro-2-hydroxy- 
benzylidene)J -L-alanine (II).
L-alanine (267.3 mg, 3 mmole), 
tétraméthylammonium hydroxide (2.46 ml/mmole, 3 mmole)
and 5-chloro-2-hydroxybenzophenone (698 mg, 3 mmole) 
were diluted with methanol ( 20 ml) and the 
reaction mixture was kept over a few sticks of 
molecular sieves (3A) for several days until a 
homogeneous solution resulted. The mixture was 
worked up as described in (A). Yield 645 mg (71%); 
m.p 180-182 C; (a)^-24 (c 4, methanol); mass 
spectrum m/e 259(MH+-COOH); Found C, 63.0; H, 4.7;
N, 4.5. ' c16HllfClN03 requires C, 63.3; H,4.6; N, 4.6%.
Preparation of N- fcct-phenyl-(5— chloro-2— hydroxy- 
benzyl idene)J -L-valine (III)
L-valine (351.5 mg, 3 mmole), tetra- 
méthylammonium hydroxide (2.46 ml/mmole, 3 mmole) 
and 5-chloro-2-hydroxybenzophenone ( 698 mg, 3 mmole) 
were diluted with methanol 20 ml and the reaction 
mixture was kept over a few sticks of molecular 
sieves (3A) for a few days until a homogeneous 
solution resulted. The mixture was worked up as
odesribed in (A). Yield 526 mg(53%); m.p. 145-146 C; 
(gO ĵ -52 ; mass spectrum m/e 287 (MH+-C00H) ; Found
C, 65.3; H, 5.5; N,4.4. ^gH^gClNO^ reclu^res C,
65.2; H, 5.5; N, 4.2 %.
Preparation of N- [ot-phenyl-(2-hydroxy-5-methyl- 
benzylidene)] -L-leucine (IV).
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L-leucine (393.5 mg, 3 mmole), tetra- 
methylammnium hydroxide (2.46 ml/mmole, 3 mmole) 
and 2-hydroxy-5-methylbenzophenone (636 mg,
3 mmole) were diluted with methanol ( 20 ml) and 
the reaction mixture was kept over a few sticks 
of molecular sieves (3A) for several days until 
a homogeneous solution resulted. The mixture was 
worked up as described in (A). Yield 487.5 mg 
(50%);m.p 128-130 C; (a)^ -88 (c 0.5, methanol); 
mass spectrum m/e 281 (MH+-C00H); Found C, 73.7;
H, 7.1; N, 4.6. ^20^23^3 reQuires C? 73.8;
H, 7.1; N, 4.3 %.
Preparation of Na-t-butyloxycarbonvl-N£-[ct-
phenyl-(5-chloro-2-hydroxvbenzvlidene)1 -L-lysine (V).
Na-Boc-L-lysine (741 mg, 3 mmole),
tétraméthylammonium hydroxide (3 mmole) and 5-
chloro-2-hydroxybenzophenone (698 mg, 3 mmole)
were mixed and diluted with methanol (20 ml). After
leaving over molecular sieves (3A) for several
days, the mixture was worked up as described in
(A). The ethyl acetate-ether extract yielded the
free acid derivative as a yellow hygroscopic foam.
V (chloroform) 3450, 1690 (urethane), 1720 (acid) max
and 1610 (imine) cm” . Hass spectrum m/e 416 
(MH+-C00H). The free acid derivative was 
unstable and was converted to its dicyclohexylamine
salt by treatment with a freshly distilled 
dicyclohexylamine solution (0.4 mmole/ml). The 
yellow crystalline solid was recrystallized 
several times from ethyl acetate but a satifactory 
analysis could not be obtained. The yield was 
51%.
Preparation of Na-t-butyloxycarbonyl-Ne -Ta-phenyl- 
(2-hydroxy-5-methylbenzylidene)J -L-lysine (VI).
Na-Boc-L-lysine (741 mg, 3 mmole), 
tetramethylammonium hydroxide (2.46 ml/mmole,
3 mmole) and 2-hydroxy-5-methylbenzophenone 
(636 mg, 3 mmole) were mixed and diluted with 
methanol ( 20 ml). After leaving over molecular 
sieves (3A) for one day, the mixture was worked up 
as described in (A). The ethyl acetate-ether 
extract yielded 343 mg (78%) of a yellow oil which 
was homogeneous on t.l.c Rf 0.76 (chloroform: 
methanol:acetic acid= 14:2:1); mass spectrum m/e 396 
(MH+-C00H). The free acid derivative was used 
directly without further purification for the 
preparation of peptides.
5 rPreparation of N - |.a-phenyl-( 5-chloro-2-hydroxy- 
benzylidene)]-Na-t-butyloxycarbonyl-L-ornithine
dicyclohexylammonium salt (VII).
Na-Boc-L-ornithine (696 mg, 3 mmole),
tetramethylammonium hydroxide ( 3 mmole) and
5-chloro-2-hydroxybenzophenone (698 mg, 3 mmole)
were mixed and diluted with methanol ( 20 ml).
The reaction mixture was kept over molecular
sieves (3A) until a homogeneous solution resulted.
After removal of the solvent on a rotary evaporator
water (40 ml) was added and the unreacted ketone
was filtered off. The pH of the solution was then
adjusted to between 5-6 by careful addition of
citric acid solution (20%). The dried extract
yielded the free acid derivative as a hygroscopic
foam (313 mg, 70%). vmax^ u3o1  ̂ 3440 cm“1,
1690 cm”1 (urethane) , 1720 cm“1(acid) and 1615 cm"1
(imine); mass spectrum m/e 402 (MH+-C00H); t.l.c
Rf 0.69 (chloroform:methanol:acetic acid, 14:2:1).
The free acid was then treated with an equivalent
molar amount of dicyclohexylamine solution (0.40
mmole/ml, 3 mmole) and the solvent was removed on
a rotary evaporator. The salt crystallized on
standing and was recrystallized from methanol-ether
o oYield 282 mg( 45%); m.p 170-173 C; (a)D+22 
(c 4, methanol); Found C, 67.2; H, 8.1; N, 7.0.
^35^50^1^3^>5 re<̂ u^res C, 66.9; N, 8.0; N, 6.7 %.
Preparation of °N-[q-phenyl-(5-chloro-2-hydroxy- 
benzylidene)]-L-valyl-glycyl-methyl ester (VIII).
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Glycine methyl ester was liberated
from its salt (252 mg, 2 mmole) by dissolving in
aqueous alkali and extracting into ethyl acetate
(20 ml). The free ester was dissolved in ethyl
acetate (4 ml) and was then treated with N-fa-
phenyl- ( 5 -chloro- 2 -hydroxybenzylidene)J-L- valine
(III)(663 mg, 2 mmole). The mixture was cooled
to 0 C and N,N'-dicyclocarbodiimide (512 mg, 2 mmole)
was added. After stirring the reaction mixture
©for one hour at 0 C, the flask was left overnight 
in the refrigerator. The urea by product was then 
filtered off and the solution was evaporated.
The residue was taken up in ethyl acetate (80 ml) 
and washed in turn with citric acid (20%), water, 
sodium bicarbonate (10%) and water. The dried 
solution was evaporated to yield the crude product 
which was purified by column chromatography 
using gradient elution with benzene-chloroform 
mixtures. The ketimine dipeptide ester was 
homogeneous on t.l.c, Rf 0.70 (carbon tetrachloride: 
ethyl acetate, 1:1). The C.I mass spectrum m/e 402 
(MH+), the infrared spectrum and the melting point 
were identical with that of compound (XV) 
prepared by the solid phase technique.
- ns -
Preparation of N-[g-phenyl-(5-chloro-2-hydroxy- 
benzylidene)jf-glycyl-L-phenylalanyl-methyl ester (IX)
Phenylalanine methyl ester hydrochloride
was liberated from its salt (H37 mg, 2 mmole) by
treatment with an equivalent amount of triethylamine
(0.28 ml, 2 mmole). The free ester derivative was
then treated with N-[a-phenyl-(5-chloro-2-hydroxy-
benzylidene)]-glycine (I)(580 mg, 2 mmole). The
reaction mixture was cooled to 0 C and N,N!-dicyclo-
hexylcrarbodiimide (512 mg, 2 mmole) was added.
oAfter stirring at 0 C for one hour, the reaction
mixture was left overnight in the refrigerator.
The urea by product was then filtered off, the
solution was concentrated and the residue was taken
up in ethyl acetate (80 ml). The organic layer
was washed with citric acid (20%), water, sodium
carbonate (10%) and water. The dried solution
was crystallized from ether-light petroleum. The
yield of ketimine dipeptide ester was 230 mg
(51%). V 3300, 1730 and 1670 cm-1; C.I mass max 5 5
spectrum m/e H50 (MH+); t.l.c Rf 0.33 (carbon
. otetrachloride:ethylacetate, 8:2); m.p 97-99 C;
(a)^-16 (c 0.5, methanol); Found C, 66.7; H,5.3 
N, 6.3 %. C25H23C1N2°4 requires C, 66.6; H, 5.1;
N, 6.2 %.
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The use of Ketimine Amino Acichs in Solid Phase 
Synthesis.
B. Attachment of Ketimine Amino Acids to the 
Merrifield Resin.
Preparation of N-|*g-phenyl-(5-chloro-2-hydroxy- 
benzylidene)"!-glycyl-resin (X) .
Merrifield resin ( 1.0 g, 0.98 meq Cl/g 
resin) and N-fa-phenyl-(5-chloro-2-hydroxy- 
benzylidene)] -glycine (I)(289 mg, 1 mmole) were 
refluxed in ethyl acetate ( 5 ml) in the presence 
of triethylamine (0.14 ml, 1 mmole) for forty 
eight hours. The resin was then filtered off and 
washed in turn with ethyl acetate, ethanol, water, 
methanol and dichloromethane (10 ml). The 
washings were repeated three times for each solvent. 
The dried resin was bright yellow in colour. The 
amino acid analysis of the acid hydrolysate of the 
resin showed the presence of 0.30 mmole of glycine 
per gram of resin.
Preparation of N-[a-phenvl-(5-chloro-2-hydroxy- 
benzylidene)]-L-alanyl-resin (XI).
Using the above procedure (B). N-[a-
phenyl-(5-chloro-2-hydroxybenzylidene)3 -L-alanine 
(260 mg, 1 mmole) was condensed with Merrifield
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resin (1.0 g, 0.98 meq Cl/g resin). The amino acid 
analysis of the product indicated a substitution 
of 0.27 mmole alanine/g resin.
Preparation of N- |"a-phenyl-(5-chloro-2-hydroxy- 
benzylidene)] -L-valyl-resin (XII) #
Using the procedure (B). N-[a-phenyl- 
(5-chloro-2-hydroxybenzylidene)J-L-valine (290 mg,
1 mmole) was condensed with Merrifield resin 
(1.0 g, 0.98 meqCl/g resin). The amino acid 
analysis of the product indicated a substitution 
of 0.32 mmole valine/g resin..
Preparation of N-fot-phenyl-(2-hydroxy-5-methyl- 
benzylidene)j-L-leucyl-resin (XIII).
Using the above procedure (B). N-£a-
phenyl-(2-hydroxy-5-methylbenzylidene)]-L- 
leucine (280 mg, 1 mmole) was condensed with 
Merrifield resin (1.0 g, 0.98 meq Cl/g resin).
The amino acid analysis of the product indicated 
a substitution of 0.2 9nunole leucine/g resin.
C. General Procedure for the preparation of 
Ketimine peptide acyl resins.
i+9
Boc-amino acyl resin (1.0 g, O^O-O.^+O 
mmole/g resin) was shaken with trifluoroacetic acid- 
dichloromethane (1:1)(10 ml) for 30 minutes a 
reaction flask fitted with a sinter.glass filter and 
tap. The trifluoroacetic acid-dichloromethane 
reagent was then removed by filtration and the 
resin was washed with dichloromethane (10 ml) and 
chloroform (10 ml) (three times). The resin 
was then neutralized by shak ingthe resin with 
triethylamine-chloroform (1:9)(10 ml) for 10 
minutes.. The resin was then washed with chloroform 
(10 ml) and dichloromethane (10 ml)(three times).
The free amino acyl resin was coupled with the 
ketimine amino acid derivatives (2.5 mmoles) 
in dichloromethane ( *+ ml) and N,N1 -dicyclo hexylcarbo- 
diimide (2.5 mmol). After shaking for a further two 
hours, the resin was washed three times with 
dichloromethane (10 ml), methanol (10 ml) and 
dichloromethane (10 ml). The dry ketimine dipeptide 
resin ester was then treated as outlined below.
D. General procedure for the preparation of 
ketimine dipeptide methyl ester.
The ketimine dipeptide resin (0.5 g) 
was suspended in anhydrous methanol (20 ml) and 
triethylamine (50 mmoles per mmole of peptide).
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The reaction mixture was stirred at room temperature 
for twenty four hours. The resin was filtered 
and the filtrate was concentrated. The residue was 
then dissolved in ethyl acetate (20 ml), and the 
solution was washed with citric acid (20%, 20 ml) 
and water, and the solution was dried and 
concentrated. The transesterification product was 
recrystallized using an appropriate solvent.
Preparation of N- fa-phenyl-(5-chloro-2-hydroxy- 
benzylidene)]-L-valyl-glycyl resin ester (XIV) and 
methyl ester (XV).
Boc-glycyl resin (1.0 g, 0.35 mmole 
glycine/g resin) was deblocked with trifluoro- 
acetic acid :dichloromethane (1:1) for 3 0 minutes.
The glycyl resin ester was then coupled with 
N- fa-phenyl- ( 5-chloro-2-hydroxybenzylidene)3 -L- 
valine (IIIX307.6 mg, 0.875 mmole) as described 
in (C). Transesterification of (XIV) was 
achieved by stirring the resin (0.5 g) with 
triethylamine (1.23 ml, 8.75 mmole) in methanol 
(20 ml), and the solution was washed with citric 
acid (20%) and water, and the solution was dried 
and concentrated. The transesterification 
product was crystallized from ether-light 
petroleum. Yield 9U mg(67% based on Boc-glycyl-
* ^
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. ’’ c oresin); m.p 138-139 C; (a)^-23 (c 0.5, methanol);
Vmax3280, 1740, 1650, 1605 cm~^; C.I mass spectrum 
m/e 402 (MH+); Rf 0.45 (chloroform). Found: C, 63.1;
H, 5.9; N, 7.2 %. ^21H23C^N2̂ *+ Teclu^ es C, 62.6;
H, 5.8; N ,7.0 %.
Preparation of N- G  -phenyl-5-chloro-2-hydroxy- 
benzylidene)]-gjycyl-L-phenylalanyl resin ester (XVI) 
and methyl ester (XVII).
Boc-L-phenylalanyl resin ester (2.0 g,
0.35 mmole phenylalanine/g resin) was deblocked by 
a 30 minute treatment with trifluoroacetic acid: 
dichloromethane (1:1) at room temperature and a 
solution of N- £a-phenyl-(5-chloro-2-hydroxy- 
benzylidene)}-glycine (I)(508 mg, 1,76 mmole) in 
dichloromethane (8 ml) was added. The resin 
dipeptide ester was then worked up as described 
in (C). The resin dipeptide ester (XVI)(1.0 g) 
was then suspended in methanol (40 ml) containing 
triethylamine (2.45 ml, 17.5 mmole). After 
stirring at room temperature for twenty four hours, 
the resin was filtered off and the filtrate was 
concentrated. The residue was washed with citric 
acid (20%) and water. After evaporation of the 
solvent, the transesterification product was 
chromatographed using benzene and benzene- 
chloroform mixture to give the pure dipeptide ester
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(XVII) which was recrystallized from ether light
petroleum. The compound was identical as shown by
t.l.c Rf 0.33 (carbon tetrachloride:ethyl acetate,
8:2); V (nujol) 3300, 1730 and 1670 cm~^; C.I max . 7+ Qmass spectrum m/e 451 (MH ); m.p 97-99 C with
9
compound (IX) prepared by condensation with DCC in 
solution.
Hydrolysis and attempted hydrolysis of ketimine 
protecting group from N -[q-phenyl-(5-chloro-2- 
hydroxybenzylidene)3 -glycyl-L-phenylalanyl resin
(XVIII) .
(a) Treatment with 80% acetic acid .
A portion of the resin (XVIII)(0.2 g) 
was treated with 80% acetic acid (10 ml). After 
shaking for 24 hours at room temperature, t.l.c 
(chloroform) showed only the slightest trace of 
ketone in the mother liquor and the colour of the 
resin was still bright yellow. After 72 hours, 
the presence of ketone in the solution was no 
more pronounced and the resin was still brightly 
yellow in colour.
(b) Treatment with aqueous chloroacetic acid- 
dichloromethane reagent.
A further portion of the resin (XVIII)
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(0.2 g) was shaken with dichloromethane-75% 
chloroacetic acid (50:37X10 ml). Although a 
significant quantity of ketone was present in the 
solution after 6 hours, the resin was still yellow 
and its colour was not discharged completely after 
a 9 hours reaction period.
(c) Treatment with hydrochloric acid-tetrahydro- 
furan reagent.
A further portion of the resin (XVIII) 
(0.2 g) was shaken with 0.U N hydrochloric acid in 
tetrahydrofuran (10 ml). After 30 minutes 
treatment, the ketone could be detected in the 
mother liquor and after 2% hours the colour had 
been completely discharged from the resin.
(d) Treatment with trifluoroacetic acid: 
dichloromethane reagent.
A further portion of the resin (XVIII) 
(0.2 g) was treated with trifluoroacetic acid: 
dichloromethane (1:1)(10 ml) for 60 minutes at 
room temperature. T.l.c (chloroform) gave no 
indication of cleavage of the protecting group.
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(E) General Procedure for Amino Acid Analysis.
The peptide (approx. 50 nano mole) in
6N HC1 (2.0 ml) was hydrolysed in vacuum at 
o110 C for 24 hours. After evaporation of the
solvent in vacuo, water (1.0 ml) added. A part
of the hydrolysed residue ( 10 micro litre) was
transferred to a micro reaction vial (0.5 ml
capacity) and a solution of stable isotopically
labelled amino acids (Gly-^N, Ala-D0, Val-Dco b
and Lys^^N) ( 5 0 nano mole each) was added.
The reaction mixture was evaporated to dryness 
under a stream of nitrogen at room temperature. 
The residue was the dissolved in anhydrous 
methanol (50 micro litre) and acetic anhydride 
(10 micro litre) and molecular sieve (3A) was 
added. The vial was capped and the mixture
. ewas heated at 70 C for 10 minutes. An aliquot 
of the reaction mixture (10 micro litre) was 
then transferred to a capillary tube and the 
solvent was removed under vacuum. The dried 
residue was then introduced into the mass 
spectrometer via the solid probe inlet system.
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Preparation of Na-t-butyloxycarbonyl-NC-fa-phenyl- 
( 2-hydroxy--5-methylbenzylidene)] -L-lysyl-L-valyl- 
resin ester (XIX) and methyl ester (XX). .
Boc-L-valyl resin (2.0 g, 0.32 mmole valine/g 
resin) was deblocked with trifluoroacetic acid: 
dichloromethane (1:1) (10 ml) for 30 minutes and
. Cl ccoupled with N -t-butyloxycarbonyl-N - a-phenyl- 
(2-hydroxy-5-methylbenzylidene) -L-lysine (705 mg,
1.60 mmole) as described in (C). The protected 
dipeptide was removed from the resin (XIX) (0.5 g) 
by a twenty four hours treatment with triethylamine 
(1.12 ml, 8.0 mmole) and dry methanol (15 ml) at 
room temperature. The reaction mixture was then 
filtered, concentrated, and the residue was ’
dissolved in ethyl acetate ( 10 ml). The organic 
layer was then washed with citric acid (20%) and 
water and the solvent evaporated. The residue was 
chromatographed on silica using chloroform: 
methanol (14:2). The major fraction gave Na-t- 
butyloxyCarbonyl-N -Qx-phenyl-(2-hydroxy-5-methyl- 
benzylidene)J -L-lysyl-L-valyl methyl ester as a 
yellow oil which was homogeneous on t.l.c, Rf 0.93 
(chloroform:methanol:acetic acid, 14:2:1) and Rf 0.49 
(carbon tetrachloride: ethyl acetate, 1:1);
V (nuiol) 1730, 1670 (broad), 1610 cm-1; C.I 
mass spectrum m/e 554 (MH ).
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Preparation of N-t-butyloxycarbonyl-glycyl-glycyl- 
N£-[q-phenyl-(2-hydroxy-5-methylbenzylidene)J -L- 
lysyl-L-valyl resin ester (XXI) and methyl ester (XXII)
The protected dipeptyl resin (1,0 g) 
was deblocked with a solution of trifluoroacetic 
acidrdichloromethane (1:1)(10 ml) and the resin 
was then coupled with Boc-glycine (140 mg, 0.80 
mmole) as described in (C) to give N-t-butyloxy- 
carbonyl-glycyl-Ne-[a-phenyl-( 2-hydroxy-5-methyl- 
benzylidene)]-L-lysyl-L-valyl-resin ester. 
Transesterification of the tripeptide resin ester 
will give the protected tripeptide methyl ester.
The Boc protecting group was removed 
from the tripeptide resin ester and the resin 
was coupled once more with Boc-glycine(140 mg,
0.80 mmole). After washing the resin with dichloro- 
methane (5 x 10 ml) and methanol (3 x 10 ml), a 
part of the protected peptide resin (0.5 g) was 
treated with triethylamine (1.12 ml, 8.0 mmole) 
in methanol (20 ml). The yellow filtrate was 
evaporated to dryness and the residue was then 
taken up in ethylacetate (10 ml). The solution 
was washed with citric acid (20%) and water and 
the yellow filtrate was chromatographed on silica 
using a benzene-methanol mixture and the yellow 
y eluate ^as crystallized from ether light petroleum. 
The protected tetrapeptide methyl ester (XXII)
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was obtained as a yellow solid (55 mg, 52%); m.p 
o88-90 C; Rf 0.89 (chloroform:methanol:acetic acid, 
14:2:1) and Rf 0.55 (carbon tetrachloride:ethyl 
acetate, 1:1); C.I mass spectrum m/e 667 (MH+).
An amino acid analysis of an acid hydrolysate of 
(XXII) yielded glycine 2.08, lysine 0.96 and valine 
1 . 00.
Preparation of Na-t-butyloxycarbonyl-Ng:- (q-phenyl- 
(2-hydroxy-5-methylbenzylidene)] -L-lysyl-L-alanyl- 
resin ester (XXIII) and methyl ester (XXIV).
Boc-L-alanyl-resin ester (2.0 g, 0.24 
mmole/alanine/g resin) was deblocked with 
trifluoroacetic acid:dichloromethane (1:1)(10 ml) 
for 30 minutes and the resin was then coupled with 
the N -t-butyloxycarbonyl-N -£a-phenyl-(2-hydroxy- 
5-methylbenzylidene)J-L-lysine (VI) (528 mg, 1.2 
mmole) in dichloromethane (8 ml) as described in 
(C). The protected dipeptide was removed from the 
resin (0.5 g)(XXIII) by treatment with triethylamine 
(0.84 ml, 6.0 mmole) and dry methanol (15 ml) for 
24 hours at room temperature. The yellow solution 
was then filtered from the resin, concentrated, 
and the residue was dissolved in ethyl acetate (10 ml) 
and washed with citric acid (20%) and water and 
dried. After evaporation of the solvent, the residue
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was chromatographed using chloroform:methanol (14:2).
The major fraction gave I^-t-butyloxycarbonyl-J^- 
fa -phenyl- ( 2 -hydroxy-5 -methylbenzylidene )] -L-ly sy 1- 
L-alany1-methyl ester (38 mg, 60%) as a yellow 
oil, homogeneous on t.l.c Rf 0.88 (chloroform: 
methanol:acetic acid, 14:2:1) and Rf 0.49 (carbon 
tetrachloride : ethyl acetate, 1:1): V 3300, 1740,
1670 and 1610 cm ^; C.I mass spectrum m/e 526 (MH+).
Preparation of N-t-butyloxycarbonyl-glycyl-glycyl- 
Nc- ta-ph,enyl-( 2-hydroxy-5-methylbenzylidene)] -L- 
lysyl-L-alanyl resin ester (XXV) and methyl ester (XXVI)
The protected dipeptyl resin (XXIII)
(1.0 g) was deblocked by a 30 minute treatment with 
trifluoroacetic acid:dichloromethane (1:1, 10 ml) 
and the resin was coupled as described in (C).
The Boc protecting group was then cleaved with
trifluoroacetic acid in dichloromethane solution
and the resin was coupled once more with Boc-glycine
(105 mg, 0.60 mmole). The resin was then worked
up as described in (C). A portion of the protected
peptide was removed from the resin (XXV) (0.5 g)
by transesterification as described in (D) to yield
the protected tetrapeptide methyl ester (XXVI)
which was recrystallized from ether-light petroleum
and was obtained as yellow crystals (35 mg, 45%); ni.p 88 C
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Rf 0.89 (chloroform:methanol:acetic acid, 14:2:1) 
and Rf 0.55 (carbon tetrachloride:ethyl acetate,
1:1). An amino acid analysis of an acid hydrolysate 
of (XXVI) yielded glycine 1.98, alanine 0.95 and 
lysine 1.00.
Preparation of l^-t-butyloxycarbonyl-N6- fa-phenyl- 
(5-chloro-2-hydroxybenzylidene)]-L-ornithyl-L- 
alanyl-resin ester (XXVII) and methyl ester (XXVIII).
Boc-L-alanyl resin ester (2.0 g, 0.24 
mmole alailine/g resin) was deblocked with 
trifluoroacetic acid:dichloromethane (1:1, 10 ml)
and the resin was coupled with an ethyl acetate
oi 6 rsolution of N -t-butyloxycarbonyl-N°-£a-phenyl-
( 5-chloro-2-hydroxybenzylidene)]J -L-ornithine which
was obtained by citric acid acidification of the
corresponding dicyclohexylammonium salt (754 mg,
1.20 mmole) (VII). Part of the protected dipeptide
was removed from the resin (0.50 g) by
transesterification as described in (D). The
Na-t-butyloxycarbonyl-N°-fa-phenyl-(5-chloro-2-
hydroxybenzylidene)]-L-ornithyl-L-alanyl-methyl
ester (XXVIII) (135 mg, 51%) was obtained as a
yellow oil which was homogeneous on t.l.c Rf 0.86
(chloroform,methanol:acetic acid, 14:2:1) and Rf 0.53
(carbon tetrachloride:ethyl acetate, 1:1); and C.I
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mass spectrum m/e 532 (MH+).
Preparation of N-t-butyloxycarbonyl-glycyl-N fa - 
phenyl-(5-chloro-2-hydroxybenzylidene)l -L-ornithyl- 
L-alanyl resin ester (XXIX) and methyl ester (XXX)
The protected dipeptide resin (XXVII)
(2.0 g) was deblocked by a 30 minute treatment 
with a solution of trifluoroacetic acid¡dichloro- 
methane (1:1) (10 ml) and the resin was coupled 
with Boc-glycine (210 mg, 1.20 mmole) as 
described in (C). The protected tripeptide 
was removed from the resin (0.5 g) with 
triethylamine (1.12 ml) and methanol (20 ml). ’ 
The resin was filtered off and the yellow 
filtrate was evaporated to dryness. The residue 
was taken up in ethyl acetate (10 ml) and washed 
with citric acid (20%) and water. After 
evaporation of the solvent, the methyl ester 
derivative (XXX) was obtained as a yellow oil.
Yield 35 mg (50%); Rf 0.84 (chloroform¡methanol: 
acetic acid= 14:2:1) and Rf 0.46 (carbon tetra­
chloride : ethyl acetate, 1:1) and C.I mass spectrum 
m/e 589 (MH+). An amino acid analysis of acid 
hydrolysate yielded glycine 0.97, alanine 1.0. 
Ornithine was not determined.
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Preparation of N-t-butyloxycarbonyl-glycyl-glycyl- 
N -fa -phenyl-(5-chloro-2-hydroxybenzylidene)] -L- 
ornithyl-L-alanyl resin ester (XXXI) and methyl 
ester (XXXII). .
The protected tripeptyl resin (XXIX)
(1.0 g) was deblocked by a 30 minute treatment 
with a solution of trifluoroacetic acid :dichloro- 
methane (1:1) (10 ml) and the resin was coupled 
once again with Boc-glycine(105 mg, 0.60 mmole). 
After washing with dichloromethane (5 x 10 ml) 
and methanol (3 x 10 ml), the protected tetra­
peptide was removed from the resin by 
transesterification with triethylamine (1.12 ml) 
and methanol (20 ml). The resin was filtered' 
off and the yellow filtrate was evaporated to 
dryness. The residue was taken up in ethyl 
acetate (10 ml) and washed with citric acid 
(20%) and water. After evaporation of the 
solvent, the residue was chromatographed using 
benzene and benzene-methanol mixtures. The methyl 
ester derivative (XXXII) (HO mg, 51%) was
. pobtained as a yellow solid. M.p 92-94 C; t.l.c 
Rf 0.84 (chloroform:methanol:acetic acid, 14:2:1) 
and Rf 0.51 (carbon tetrachloride : ethyl acetate, 
1:1) and mass spectrum m/e 646 (MH+). An amino 
acid analysis.of an acid hydrolysate yielded
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alanine 1.00, glycine 1.96. Ornithine was not 
determined.
B I B L I O G R A P H Y
63
1.
2 .
. 3.
4.
5 .
6 .
7.
8 .
9.
10 .
1 1 .
12.
FISCHER, E.,
Ber. Dtsch. Chem. Ges., 1903 , 3j[, 2094 
CURTIUS, T.,
Ber. Dtsch. Chem. Ges., 1902, 3^, 3226
FINN, F.M., AND HOFMANN, K.,
J. Amer. Chem. Soc., 1965, 8_7, 64 5
BERGMANN, M. , AND ZERVAS, L.,
Ber. Dtsch. Chem. Ges., 1932, ¿5, 1192
Mc KAY, F.C., AND ALBERTSON, N.F.,
J. Amer. Chem. Soc., 1957, 7ĵ , 4686
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